CASI Pharmaceuticals (CASIF) Liabilities and Shareholders Equity (2021 - 2026)
CASI Pharmaceuticals' Liabilities and Shareholders Equity came in at $21.06 million for Q2 2026, down 32.5% from $31.2 million a year earlier.
Powered by 
Analysis
CASI Pharmaceuticals (CASIF) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends
At the end of FY2025, CASI Pharmaceuticals' Liabilities and Shareholders Equity was $25.65 million, down 52.2% from FY2024.
- Liabilities and Shareholders Equity carries a four-year compound annual growth rate of -34.4% (FY2021 to FY2025).
- Going back by year, Liabilities and Shareholders Equity was $53.67 million in FY2024, $96.23 million in FY2022 (-30.4%) and $138.3 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Liabilities and Shareholders Equity in data going back to Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | CASI Pharmaceuticals | 2.47 Mn | -18.36 Mn | - | 21.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.06 Mn |
| Dec 31, 2025 | 25.65 Mn |
| Sep 30, 2025 | 24.46 Mn |
| Jun 30, 2025 | 31.20 Mn |
| Mar 31, 2025 | 40.82 Mn |
| Dec 31, 2024 | 53.67 Mn |
| Jun 30, 2024 | 51.27 Mn |
| Mar 31, 2024 | 58.01 Mn |
| Sep 30, 2023 | 74.23 Mn |
| Jun 30, 2023 | 77.87 Mn |
| Mar 31, 2023 | 88.40 Mn |
| Dec 31, 2022 | 96.23 Mn |
| Dec 31, 2021 | 138.30 Mn |
API Access
CASI Pharmaceuticals Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CASIF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "CASIF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CASIF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();